

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 4.69611501 |
| 2 | formation of translation preinitiation complex (GO:0001731) | 4.62405887 |
| 3 | ribosomal small subunit biogenesis (GO:0042274) | 4.43852687 |
| 4 | ribosomal small subunit assembly (GO:0000028) | 4.32629320 |
| 5 | maturation of SSU-rRNA (GO:0030490) | 4.23037854 |
| 6 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.12665692 |
| 7 | viral transcription (GO:0019083) | 3.90995200 |
| 8 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.89891068 |
| 9 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.88782692 |
| 10 | DNA strand elongation (GO:0022616) | 3.88021900 |
| 11 | translational termination (GO:0006415) | 3.79084692 |
| 12 | DNA replication initiation (GO:0006270) | 3.78117243 |
| 13 | protein maturation by protein folding (GO:0022417) | 3.76213707 |
| 14 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.68990022 |
| 15 | rRNA modification (GO:0000154) | 3.66574674 |
| 16 | pyrimidine nucleoside salvage (GO:0043097) | 3.65515893 |
| 17 | pyrimidine-containing compound salvage (GO:0008655) | 3.65515893 |
| 18 | ribosome biogenesis (GO:0042254) | 3.60326951 |
| 19 | pseudouridine synthesis (GO:0001522) | 3.60291016 |
| 20 | nucleobase biosynthetic process (GO:0046112) | 3.59309305 |
| 21 | telomere maintenance via recombination (GO:0000722) | 3.54699143 |
| 22 | neutrophil activation involved in immune response (GO:0002283) | 3.54536073 |
| 23 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.54433021 |
| 24 | proteasome assembly (GO:0043248) | 3.53340830 |
| 25 | translational elongation (GO:0006414) | 3.46843672 |
| 26 | cotranslational protein targeting to membrane (GO:0006613) | 3.46800015 |
| 27 | protein targeting to ER (GO:0045047) | 3.44697173 |
| 28 | DNA unwinding involved in DNA replication (GO:0006268) | 3.42217068 |
| 29 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.38215362 |
| 30 | translational initiation (GO:0006413) | 3.37594644 |
| 31 | ribosomal large subunit biogenesis (GO:0042273) | 3.37426903 |
| 32 | purine nucleobase biosynthetic process (GO:0009113) | 3.35492080 |
| 33 | DNA replication checkpoint (GO:0000076) | 3.34256932 |
| 34 | establishment of integrated proviral latency (GO:0075713) | 3.31047765 |
| 35 | protein localization to endoplasmic reticulum (GO:0070972) | 3.27160304 |
| 36 | translation (GO:0006412) | 3.25312177 |
| 37 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.24610601 |
| 38 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.22862205 |
| 39 | cullin deneddylation (GO:0010388) | 3.22628875 |
| 40 | mitotic recombination (GO:0006312) | 3.19998899 |
| 41 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.18978327 |
| 42 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.18978327 |
| 43 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.16194192 |
| 44 | negative regulation of ligase activity (GO:0051352) | 3.16194192 |
| 45 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.15992220 |
| 46 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.15992220 |
| 47 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.15992220 |
| 48 | rRNA processing (GO:0006364) | 3.14979743 |
| 49 | protein deneddylation (GO:0000338) | 3.14555138 |
| 50 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.13391660 |
| 51 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.13077744 |
| 52 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.13039139 |
| 53 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.13039139 |
| 54 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.12206205 |
| 55 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.11725006 |
| 56 | pentose metabolic process (GO:0019321) | 3.11398309 |
| 57 | spliceosomal snRNP assembly (GO:0000387) | 3.11065761 |
| 58 | rRNA methylation (GO:0031167) | 3.10212298 |
| 59 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.10181836 |
| 60 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.10181836 |
| 61 | nucleotide salvage (GO:0043173) | 3.09520810 |
| 62 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.08799569 |
| 63 | viral life cycle (GO:0019058) | 3.08466185 |
| 64 | termination of RNA polymerase III transcription (GO:0006386) | 3.08286816 |
| 65 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.08286816 |
| 66 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.05019267 |
| 67 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.03604480 |
| 68 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.03342487 |
| 69 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.01254339 |
| 70 | rRNA metabolic process (GO:0016072) | 3.01057848 |
| 71 | GDP-mannose metabolic process (GO:0019673) | 3.00618105 |
| 72 | protein localization to kinetochore (GO:0034501) | 3.00591191 |
| 73 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.00399195 |
| 74 | cellular component biogenesis (GO:0044085) | 2.99404355 |
| 75 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.99116031 |
| 76 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.97259961 |
| 77 | folic acid metabolic process (GO:0046655) | 2.96425354 |
| 78 | pentose-phosphate shunt (GO:0006098) | 2.95115277 |
| 79 | cellular protein complex disassembly (GO:0043624) | 2.93887596 |
| 80 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.91314442 |
| 81 | Golgi transport vesicle coating (GO:0048200) | 2.86580462 |
| 82 | COPI coating of Golgi vesicle (GO:0048205) | 2.86580462 |
| 83 | response to peptidoglycan (GO:0032494) | 2.85297628 |
| 84 | telomere maintenance via telomere lengthening (GO:0010833) | 2.85108744 |
| 85 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.84380144 |
| 86 | ribosome assembly (GO:0042255) | 2.82688893 |
| 87 | nucleoside salvage (GO:0043174) | 2.81688269 |
| 88 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.78436221 |
| 89 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.78436221 |
| 90 | regulation of mitochondrial translation (GO:0070129) | 2.78139817 |
| 91 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.77152376 |
| 92 | pinocytosis (GO:0006907) | 2.76381694 |
| 93 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.75268951 |
| 94 | oxidative phosphorylation (GO:0006119) | 2.73800184 |
| 95 | NADPH regeneration (GO:0006740) | 2.72568711 |
| 96 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.72206330 |
| 97 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.72116328 |
| 98 | regulation of gene silencing by miRNA (GO:0060964) | 2.72116328 |
| 99 | regulation of gene silencing by RNA (GO:0060966) | 2.72116328 |
| 100 | negative regulation of gene silencing (GO:0060969) | 2.71398772 |
| 101 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.70853920 |
| 102 | autophagic vacuole fusion (GO:0000046) | 2.70241316 |
| 103 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.69944070 |
| 104 | transcription from mitochondrial promoter (GO:0006390) | 2.67439545 |
| 105 | protein complex disassembly (GO:0043241) | 2.67255592 |
| 106 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.66662438 |
| 107 | regulation of superoxide anion generation (GO:0032928) | 2.65802128 |
| 108 | positive regulation of cell cycle arrest (GO:0071158) | 2.64911092 |
| 109 | cell cycle G1/S phase transition (GO:0044843) | 2.64732744 |
| 110 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.64732744 |
| 111 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.61651536 |
| 112 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.61507726 |
| 113 | transcription from RNA polymerase I promoter (GO:0006360) | 2.60242502 |
| 114 | macromolecular complex disassembly (GO:0032984) | 2.60191238 |
| 115 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.59793378 |
| 116 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.59682483 |
| 117 | mitotic nuclear envelope disassembly (GO:0007077) | 2.59671728 |
| 118 | IMP biosynthetic process (GO:0006188) | 2.59169958 |
| 119 | purine nucleotide salvage (GO:0032261) | 2.58326406 |
| 120 | protein localization to chromosome, centromeric region (GO:0071459) | 2.58270409 |
| 121 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.56754611 |
| 122 | heterochromatin organization (GO:0070828) | 2.56628721 |
| 123 | establishment of viral latency (GO:0019043) | 2.56234934 |
| 124 | L-methionine salvage (GO:0071267) | 2.54701051 |
| 125 | L-methionine biosynthetic process (GO:0071265) | 2.54701051 |
| 126 | amino acid salvage (GO:0043102) | 2.54701051 |
| 127 | deoxyribonucleotide catabolic process (GO:0009264) | 2.53187121 |
| 128 | deoxyribose phosphate catabolic process (GO:0046386) | 2.52866192 |
| 129 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.50458824 |
| 130 | response to interferon-beta (GO:0035456) | 2.50121035 |
| 131 | glucose catabolic process (GO:0006007) | 2.50086108 |
| 132 | positive regulation of ligase activity (GO:0051351) | 2.47902286 |
| 133 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.46898692 |
| 134 | glycosphingolipid catabolic process (GO:0046479) | 2.45954941 |
| 135 | NIK/NF-kappaB signaling (GO:0038061) | 2.45869833 |
| 136 | regulation of cellular amine metabolic process (GO:0033238) | 2.45734899 |
| 137 | GMP metabolic process (GO:0046037) | 2.43067330 |
| 138 | immunoglobulin mediated immune response (GO:0016064) | 2.41587846 |
| 139 | negative regulation of B cell apoptotic process (GO:0002903) | 2.40964391 |
| 140 | proline biosynthetic process (GO:0006561) | 2.38890861 |
| 141 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.35729627 |
| 142 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.27668083 |
| 143 | mitochondrial calcium ion transport (GO:0006851) | 2.27349105 |
| 144 | cytochrome complex assembly (GO:0017004) | 2.27303466 |
| 145 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.27200698 |
| 146 | mitotic nuclear envelope reassembly (GO:0007084) | 2.26512173 |
| 147 | nuclear envelope reassembly (GO:0031468) | 2.26512173 |
| 148 | protein targeting to mitochondrion (GO:0006626) | 2.26007593 |
| 149 | protein retention in ER lumen (GO:0006621) | 2.25817533 |
| 150 | glycolipid catabolic process (GO:0019377) | 2.25724519 |
| 151 | lipoxygenase pathway (GO:0019372) | 2.25552595 |
| 152 | chaperone-mediated protein transport (GO:0072321) | 2.24197402 |
| 153 | cellular metabolic compound salvage (GO:0043094) | 2.22772217 |
| 154 | regulation of ligase activity (GO:0051340) | 2.22707104 |
| 155 | organelle membrane fusion (GO:0090174) | 2.22464353 |
| 156 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.21983472 |
| 157 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.21564936 |
| 158 | ATP synthesis coupled proton transport (GO:0015986) | 2.21564936 |
| 159 | pyrimidine nucleoside biosynthetic process (GO:0046134) | 2.21560980 |
| 160 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.19244541 |
| 161 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.18939789 |
| 162 | metallo-sulfur cluster assembly (GO:0031163) | 2.16658199 |
| 163 | iron-sulfur cluster assembly (GO:0016226) | 2.16658199 |
| 164 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.16090722 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.16143884 |
| 2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.81910273 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.56293011 |
| 4 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.25744610 |
| 5 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.11135950 |
| 6 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.05234234 |
| 7 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.94609981 |
| 8 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.94286849 |
| 9 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.83501702 |
| 10 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.79344919 |
| 11 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.62828731 |
| 12 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.55988643 |
| 13 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.55298479 |
| 14 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.34618604 |
| 15 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.32300104 |
| 16 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.22256941 |
| 17 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.18242111 |
| 18 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.14934623 |
| 19 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.13712479 |
| 20 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.13023547 |
| 21 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.05564186 |
| 22 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.04648562 |
| 23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.99946660 |
| 24 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.96963375 |
| 25 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.96963375 |
| 26 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.96963375 |
| 27 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.94692144 |
| 28 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.94443119 |
| 29 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.92106242 |
| 30 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.91843772 |
| 31 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.85001953 |
| 32 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.83242029 |
| 33 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.80820961 |
| 34 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.79605234 |
| 35 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.78769408 |
| 36 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.77260377 |
| 37 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.73180551 |
| 38 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.71688744 |
| 39 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.71532647 |
| 40 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.71271826 |
| 41 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.70592456 |
| 42 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.68361213 |
| 43 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.66232959 |
| 44 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.60970227 |
| 45 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.59960799 |
| 46 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.57939607 |
| 47 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.56364975 |
| 48 | * SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.55878477 |
| 49 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53928454 |
| 50 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.53715219 |
| 51 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.53158152 |
| 52 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.52328124 |
| 53 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.48746316 |
| 54 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.47704356 |
| 55 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.47673299 |
| 56 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45985518 |
| 57 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.44416586 |
| 58 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.42859229 |
| 59 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.42008597 |
| 60 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.41195810 |
| 61 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.36782622 |
| 62 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.36038216 |
| 63 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.30925479 |
| 64 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.30658618 |
| 65 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.29508158 |
| 66 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.28575454 |
| 67 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.28525744 |
| 68 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.28522338 |
| 69 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.27741567 |
| 70 | P68_20966046_ChIP-Seq_HELA_Human | 1.26063790 |
| 71 | MAF_26560356_Chip-Seq_TH1_Human | 1.25382931 |
| 72 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.25359264 |
| 73 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.24453248 |
| 74 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.24317285 |
| 75 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.24150686 |
| 76 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.24107565 |
| 77 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.23776803 |
| 78 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.23580904 |
| 79 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.23051238 |
| 80 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.22922321 |
| 81 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.21939057 |
| 82 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.21198720 |
| 83 | MAF_26560356_Chip-Seq_TH2_Human | 1.19796066 |
| 84 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.18676497 |
| 85 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18571110 |
| 86 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.18423010 |
| 87 | UTX_26944678_Chip-Seq_JUKART_Human | 1.18313989 |
| 88 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.17815880 |
| 89 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.15484215 |
| 90 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.15236497 |
| 91 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.14584067 |
| 92 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13528793 |
| 93 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.13513661 |
| 94 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12689848 |
| 95 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.11648921 |
| 96 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.11590101 |
| 97 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.11495941 |
| 98 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.11471358 |
| 99 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.11207825 |
| 100 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.10743620 |
| 101 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.10357154 |
| 102 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.08964395 |
| 103 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08891554 |
| 104 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.08808352 |
| 105 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08186785 |
| 106 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.07327859 |
| 107 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.07192909 |
| 108 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.07107286 |
| 109 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06318091 |
| 110 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.06304520 |
| 111 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.05629409 |
| 112 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.05621578 |
| 113 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.05466987 |
| 114 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.04824662 |
| 115 | ATF3_27146783_Chip-Seq_COLON_Human | 1.04568980 |
| 116 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.04540869 |
| 117 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.04178595 |
| 118 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.04133331 |
| 119 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.03509492 |
| 120 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.02954889 |
| 121 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 1.01624938 |
| 122 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.01057461 |
| 123 | MYC_22102868_ChIP-Seq_BL_Human | 1.00308071 |
| 124 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.99426607 |
| 125 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.99415539 |
| 126 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.98670977 |
| 127 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.97685452 |
| 128 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.97087645 |
| 129 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.95552440 |
| 130 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.94136155 |
| 131 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 0.92630910 |
| 132 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91359148 |
| 133 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.87779511 |
| 134 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.86320116 |
| 135 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85151353 |
| 136 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.84796231 |
| 137 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.82962071 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003806_abnormal_nucleotide_metabolis | 4.64090704 |
| 2 | MP0003693_abnormal_embryo_hatching | 4.23367727 |
| 3 | MP0004957_abnormal_blastocyst_morpholog | 3.99253936 |
| 4 | MP0003191_abnormal_cellular_cholesterol | 3.12380854 |
| 5 | MP0008057_abnormal_DNA_replication | 3.10163183 |
| 6 | MP0008260_abnormal_autophagy | 2.98370920 |
| 7 | MP0003077_abnormal_cell_cycle | 2.86468013 |
| 8 | MP0003111_abnormal_nucleus_morphology | 2.78950293 |
| 9 | MP0010094_abnormal_chromosome_stability | 2.62357862 |
| 10 | MP0003186_abnormal_redox_activity | 2.45656867 |
| 11 | MP0008932_abnormal_embryonic_tissue | 2.43353583 |
| 12 | MP0003283_abnormal_digestive_organ | 2.36009111 |
| 13 | MP0005451_abnormal_body_composition | 2.27417479 |
| 14 | MP0008058_abnormal_DNA_repair | 2.21194697 |
| 15 | MP0010352_gastrointestinal_tract_polyps | 2.20086086 |
| 16 | MP0004264_abnormal_extraembryonic_tissu | 2.13442490 |
| 17 | MP0005464_abnormal_platelet_physiology | 2.08758911 |
| 18 | MP0008007_abnormal_cellular_replicative | 2.08302494 |
| 19 | MP0009333_abnormal_splenocyte_physiolog | 1.87820358 |
| 20 | MP0003303_peritoneal_inflammation | 1.82607735 |
| 21 | MP0004133_heterotaxia | 1.78498096 |
| 22 | MP0003315_abnormal_perineum_morphology | 1.76121066 |
| 23 | MP0005075_abnormal_melanosome_morpholog | 1.76011709 |
| 24 | MP0002877_abnormal_melanocyte_morpholog | 1.75443989 |
| 25 | MP0002419_abnormal_innate_immunity | 1.75068245 |
| 26 | MP0001730_embryonic_growth_arrest | 1.74589247 |
| 27 | MP0000490_abnormal_crypts_of | 1.65519351 |
| 28 | MP0000350_abnormal_cell_proliferation | 1.59787767 |
| 29 | MP0009278_abnormal_bone_marrow | 1.56421314 |
| 30 | MP0003172_abnormal_lysosome_physiology | 1.56092564 |
| 31 | MP0002796_impaired_skin_barrier | 1.51081944 |
| 32 | MP0001873_stomach_inflammation | 1.50768027 |
| 33 | MP0005501_abnormal_skin_physiology | 1.49762053 |
| 34 | MP0009840_abnormal_foam_cell | 1.48059327 |
| 35 | MP0002723_abnormal_immune_serum | 1.45201740 |
| 36 | MP0006292_abnormal_olfactory_placode | 1.41600817 |
| 37 | MP0001819_abnormal_immune_cell | 1.41481894 |
| 38 | MP0003724_increased_susceptibility_to | 1.41140964 |
| 39 | MP0003718_maternal_effect | 1.41124549 |
| 40 | MP0002420_abnormal_adaptive_immunity | 1.39324650 |
| 41 | MP0001845_abnormal_inflammatory_respons | 1.37453053 |
| 42 | MP0005058_abnormal_lysosome_morphology | 1.36081428 |
| 43 | MP0003786_premature_aging | 1.34484116 |
| 44 | MP0002396_abnormal_hematopoietic_system | 1.33100870 |
| 45 | MP0010030_abnormal_orbit_morphology | 1.33073982 |
| 46 | MP0000313_abnormal_cell_death | 1.32208898 |
| 47 | MP0008469_abnormal_protein_level | 1.31700995 |
| 48 | MP0000537_abnormal_urethra_morphology | 1.30806928 |
| 49 | MP0003123_paternal_imprinting | 1.29292040 |
| 50 | MP0001533_abnormal_skeleton_physiology | 1.28124210 |
| 51 | MP0000343_altered_response_to | 1.27834697 |
| 52 | MP0001697_abnormal_embryo_size | 1.27085088 |
| 53 | MP0005380_embryogenesis_phenotype | 1.27017485 |
| 54 | MP0001672_abnormal_embryogenesis/_devel | 1.27017485 |
| 55 | MP0005387_immune_system_phenotype | 1.26333668 |
| 56 | MP0001790_abnormal_immune_system | 1.26333668 |
| 57 | MP0009785_altered_susceptibility_to | 1.23573194 |
| 58 | MP0006036_abnormal_mitochondrial_physio | 1.23465407 |
| 59 | MP0006035_abnormal_mitochondrial_morpho | 1.23308172 |
| 60 | MP0003453_abnormal_keratinocyte_physiol | 1.22416634 |
| 61 | MP0002080_prenatal_lethality | 1.21488549 |
| 62 | MP0000858_altered_metastatic_potential | 1.20732807 |
| 63 | MP0004947_skin_inflammation | 1.19977877 |
| 64 | MP0002653_abnormal_ependyma_morphology | 1.18845292 |
| 65 | MP0002019_abnormal_tumor_incidence | 1.18746976 |
| 66 | MP0002139_abnormal_hepatobiliary_system | 1.17506754 |
| 67 | MP0003984_embryonic_growth_retardation | 1.16508889 |
| 68 | MP0008875_abnormal_xenobiotic_pharmacok | 1.16321167 |
| 69 | MP0005266_abnormal_metabolism | 1.15876305 |
| 70 | MP0000358_abnormal_cell_content/ | 1.15405089 |
| 71 | MP0003705_abnormal_hypodermis_morpholog | 1.13872945 |
| 72 | MP0002085_abnormal_embryonic_tissue | 1.13670860 |
| 73 | MP0002088_abnormal_embryonic_growth/wei | 1.13466542 |
| 74 | MP0010234_abnormal_vibrissa_follicle | 1.13216960 |
| 75 | MP0003075_altered_response_to | 1.12467527 |
| 76 | MP0002132_abnormal_respiratory_system | 1.11750285 |
| 77 | MP0003436_decreased_susceptibility_to | 1.09545291 |
| 78 | MP0002086_abnormal_extraembryonic_tissu | 1.09195921 |
| 79 | MP0005365_abnormal_bile_salt | 1.08966616 |
| 80 | MP0005410_abnormal_fertilization | 1.08798041 |
| 81 | MP0008004_abnormal_stomach_pH | 1.02471573 |
| 82 | MP0000477_abnormal_intestine_morphology | 1.01637347 |
| 83 | MP0001293_anophthalmia | 1.00675127 |
| 84 | MP0004185_abnormal_adipocyte_glucose | 0.99519158 |
| 85 | MP0001835_abnormal_antigen_presentation | 0.99329616 |
| 86 | MP0002210_abnormal_sex_determination | 0.98635524 |
| 87 | MP0000689_abnormal_spleen_morphology | 0.98567594 |
| 88 | MP0003011_delayed_dark_adaptation | 0.98180698 |
| 89 | MP0003119_abnormal_digestive_system | 0.97504053 |
| 90 | MP0003866_abnormal_defecation | 0.97121107 |
| 91 | MP0004197_abnormal_fetal_growth/weight/ | 0.97033246 |
| 92 | MP0000703_abnormal_thymus_morphology | 0.96523100 |
| 93 | MP0005083_abnormal_biliary_tract | 0.96366669 |
| 94 | MP0005397_hematopoietic_system_phenotyp | 0.95553824 |
| 95 | MP0001545_abnormal_hematopoietic_system | 0.95553824 |
| 96 | MP0006082_CNS_inflammation | 0.94502589 |
| 97 | MP0010155_abnormal_intestine_physiology | 0.94231782 |
| 98 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.93151112 |
| 99 | MP0001145_abnormal_male_reproductive | 0.92935812 |
| 100 | MP0005023_abnormal_wound_healing | 0.91786796 |
| 101 | MP0002254_reproductive_system_inflammat | 0.91612849 |
| 102 | MP0001216_abnormal_epidermal_layer | 0.89899837 |
| 103 | MP0002722_abnormal_immune_system | 0.89880235 |
| 104 | MP0009764_decreased_sensitivity_to | 0.89684664 |
| 105 | MP0001727_abnormal_embryo_implantation | 0.89583876 |
| 106 | MP0000609_abnormal_liver_physiology | 0.89322859 |
| 107 | MP0005025_abnormal_response_to | 0.89073768 |
| 108 | MP0004381_abnormal_hair_follicle | 0.88846239 |
| 109 | MP0002084_abnormal_developmental_patter | 0.87370533 |
| 110 | MP0003890_abnormal_embryonic-extraembry | 0.86706639 |
| 111 | MP0005671_abnormal_response_to | 0.86565957 |
| 112 | MP0001764_abnormal_homeostasis | 0.86266147 |
| 113 | MP0002405_respiratory_system_inflammati | 0.85796861 |
| 114 | MP0003448_altered_tumor_morphology | 0.84558435 |
| 115 | MP0002429_abnormal_blood_cell | 0.84349448 |
| 116 | MP0000678_abnormal_parathyroid_gland | 0.84082749 |
| 117 | MP0001661_extended_life_span | 0.83606717 |
| 118 | MP0001929_abnormal_gametogenesis | 0.83212238 |
| 119 | MP0001881_abnormal_mammary_gland | 0.82735919 |
| 120 | MP0000598_abnormal_liver_morphology | 0.82603884 |
| 121 | MP0003566_abnormal_cell_adhesion | 0.82466559 |
| 122 | MP0003567_abnormal_fetal_cardiomyocyte | 0.80614879 |
| 123 | MP0009931_abnormal_skin_appearance | 0.80171787 |
| 124 | MP0002148_abnormal_hypersensitivity_rea | 0.80075258 |
| 125 | MP0002398_abnormal_bone_marrow | 0.79505327 |
| 126 | MP0000015_abnormal_ear_pigmentation | 0.79241183 |
| 127 | MP0009643_abnormal_urine_homeostasis | 0.79136465 |
| 128 | MP0004858_abnormal_nervous_system | 0.78890211 |
| 129 | MP0001853_heart_inflammation | 0.76146836 |
| 130 | MP0005319_abnormal_enzyme/_coenzyme | 0.76065027 |
| 131 | MP0003763_abnormal_thymus_physiology | 0.74859079 |
| 132 | MP0001849_ear_inflammation | 0.74316064 |
| 133 | MP0003950_abnormal_plasma_membrane | 0.74216450 |
| 134 | MP0005360_urolithiasis | 0.73245223 |
| 135 | MP0000716_abnormal_immune_system | 0.72252900 |
| 136 | MP0000462_abnormal_digestive_system | 0.70041869 |
| 137 | MP0002452_abnormal_antigen_presenting | 0.69781571 |
| 138 | MP0010307_abnormal_tumor_latency | 0.69543013 |
| 139 | MP0005332_abnormal_amino_acid | 0.69216428 |
| 140 | MP0005408_hypopigmentation | 0.68035259 |
| 141 | MP0000685_abnormal_immune_system | 0.68016151 |
| 142 | MP0000653_abnormal_sex_gland | 0.67837270 |
| 143 | MP0000516_abnormal_urinary_system | 0.66809622 |
| 144 | MP0005367_renal/urinary_system_phenotyp | 0.66809622 |
| 145 | MP0005376_homeostasis/metabolism_phenot | 0.66659993 |
| 146 | MP0001800_abnormal_humoral_immune | 0.65811823 |
| 147 | MP0005000_abnormal_immune_tolerance | 0.65781325 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Multiple enchondromatosis (HP:0005701) | 4.28756767 |
| 2 | Trismus (HP:0000211) | 4.10907365 |
| 3 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.85212411 |
| 4 | Abnormality of glycolipid metabolism (HP:0010969) | 3.65021982 |
| 5 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.65021982 |
| 6 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.65021982 |
| 7 | Abnormal number of erythroid precursors (HP:0012131) | 3.64232546 |
| 8 | Recurrent abscess formation (HP:0002722) | 3.34323247 |
| 9 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 3.33521069 |
| 10 | Abnormality of macrophages (HP:0004311) | 3.20336309 |
| 11 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.17018023 |
| 12 | Degeneration of anterior horn cells (HP:0002398) | 3.16461000 |
| 13 | Abnormality of the anterior horn cell (HP:0006802) | 3.16461000 |
| 14 | Breast hypoplasia (HP:0003187) | 3.12557525 |
| 15 | Poikiloderma (HP:0001029) | 3.07870553 |
| 16 | Reticulocytopenia (HP:0001896) | 3.07550281 |
| 17 | Type I transferrin isoform profile (HP:0003642) | 3.06841901 |
| 18 | Aplastic anemia (HP:0001915) | 3.06811148 |
| 19 | Purpura (HP:0000979) | 3.01148224 |
| 20 | Testicular atrophy (HP:0000029) | 2.93672274 |
| 21 | Carpal bone hypoplasia (HP:0001498) | 2.92140449 |
| 22 | Obstructive lung disease (HP:0006536) | 2.87940295 |
| 23 | Chronic obstructive pulmonary disease (HP:0006510) | 2.87940295 |
| 24 | Rough bone trabeculation (HP:0100670) | 2.87007500 |
| 25 | Vacuolated lymphocytes (HP:0001922) | 2.84569474 |
| 26 | Cerebral hypomyelination (HP:0006808) | 2.82416080 |
| 27 | Birth length less than 3rd percentile (HP:0003561) | 2.75283892 |
| 28 | Recurrent bacterial skin infections (HP:0005406) | 2.72960633 |
| 29 | Reduced antithrombin III activity (HP:0001976) | 2.72067968 |
| 30 | Hepatosplenomegaly (HP:0001433) | 2.70604101 |
| 31 | Increased cerebral lipofuscin (HP:0011813) | 2.70589817 |
| 32 | Microretrognathia (HP:0000308) | 2.66891031 |
| 33 | Tongue fasciculations (HP:0001308) | 2.64950610 |
| 34 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.64060937 |
| 35 | Increased intramyocellular lipid droplets (HP:0012240) | 2.62845323 |
| 36 | Ragged-red muscle fibers (HP:0003200) | 2.61894678 |
| 37 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.60098474 |
| 38 | Abnormality of the 1st metacarpal (HP:0010009) | 2.59765326 |
| 39 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.59071701 |
| 40 | Eczematoid dermatitis (HP:0000976) | 2.56713317 |
| 41 | Vertebral compression fractures (HP:0002953) | 2.55668853 |
| 42 | Increased muscle lipid content (HP:0009058) | 2.55555585 |
| 43 | Oral leukoplakia (HP:0002745) | 2.51834581 |
| 44 | Hypertensive crisis (HP:0100735) | 2.51497554 |
| 45 | Macrocytic anemia (HP:0001972) | 2.51438184 |
| 46 | Hypokinesia (HP:0002375) | 2.47709493 |
| 47 | Progressive neurologic deterioration (HP:0002344) | 2.46309306 |
| 48 | 3-Methylglutaconic aciduria (HP:0003535) | 2.40304597 |
| 49 | Dysostosis multiplex (HP:0000943) | 2.36978674 |
| 50 | Increased serum ferritin (HP:0003281) | 2.34442417 |
| 51 | Muscle fibrillation (HP:0010546) | 2.33816807 |
| 52 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.33523702 |
| 53 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.33523702 |
| 54 | Abnormal protein glycosylation (HP:0012346) | 2.33523702 |
| 55 | Abnormal glycosylation (HP:0012345) | 2.33523702 |
| 56 | Selective tooth agenesis (HP:0001592) | 2.31152791 |
| 57 | Pallor (HP:0000980) | 2.29787365 |
| 58 | Respiratory difficulties (HP:0002880) | 2.29387752 |
| 59 | Systemic lupus erythematosus (HP:0002725) | 2.29150737 |
| 60 | Ileus (HP:0002595) | 2.29102620 |
| 61 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.28548611 |
| 62 | Abnormal trabecular bone morphology (HP:0100671) | 2.27820997 |
| 63 | Hepatic necrosis (HP:0002605) | 2.27711171 |
| 64 | Abnormality of glycolysis (HP:0004366) | 2.27504818 |
| 65 | Increased serum pyruvate (HP:0003542) | 2.27504818 |
| 66 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.27033906 |
| 67 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.27033906 |
| 68 | Increased CSF lactate (HP:0002490) | 2.27026503 |
| 69 | Hepatocellular necrosis (HP:0001404) | 2.25935828 |
| 70 | Progressive muscle weakness (HP:0003323) | 2.25577739 |
| 71 | Mitochondrial inheritance (HP:0001427) | 2.25322454 |
| 72 | Increased serum lactate (HP:0002151) | 2.25195327 |
| 73 | Short humerus (HP:0005792) | 2.23798829 |
| 74 | Cholecystitis (HP:0001082) | 2.23359386 |
| 75 | Abnormal gallbladder physiology (HP:0012438) | 2.23359386 |
| 76 | Poor head control (HP:0002421) | 2.23213181 |
| 77 | Increased hepatocellular lipid droplets (HP:0006565) | 2.21731459 |
| 78 | Loss of speech (HP:0002371) | 2.21682717 |
| 79 | Abnormal cartilage morphology (HP:0002763) | 2.20497448 |
| 80 | Pustule (HP:0200039) | 2.20343524 |
| 81 | Lipid accumulation in hepatocytes (HP:0006561) | 2.18972376 |
| 82 | Rectal fistula (HP:0100590) | 2.17144715 |
| 83 | Rectovaginal fistula (HP:0000143) | 2.17144715 |
| 84 | Acute encephalopathy (HP:0006846) | 2.15435179 |
| 85 | Acute necrotizing encephalopathy (HP:0006965) | 2.15368282 |
| 86 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.13973865 |
| 87 | Exertional dyspnea (HP:0002875) | 2.13710471 |
| 88 | Microvesicular hepatic steatosis (HP:0001414) | 2.11357513 |
| 89 | Hypoplasia of the radius (HP:0002984) | 2.10796424 |
| 90 | Pancytopenia (HP:0001876) | 2.10080678 |
| 91 | Vaginal fistula (HP:0004320) | 2.07785924 |
| 92 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.05660436 |
| 93 | Absent thumb (HP:0009777) | 2.05043730 |
| 94 | Short phalanx of the thumb (HP:0009660) | 2.03882194 |
| 95 | Distal lower limb muscle weakness (HP:0009053) | 2.03709286 |
| 96 | Abnormality of the preputium (HP:0100587) | 2.03186070 |
| 97 | Premature ovarian failure (HP:0008209) | 2.03003484 |
| 98 | Cheilitis (HP:0100825) | 2.01035808 |
| 99 | Cleft eyelid (HP:0000625) | 2.00922710 |
| 100 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.99938436 |
| 101 | Absent radius (HP:0003974) | 1.99020567 |
| 102 | Impulsivity (HP:0100710) | 1.98651341 |
| 103 | Increased IgM level (HP:0003496) | 1.97628844 |
| 104 | Septate vagina (HP:0001153) | 1.97085534 |
| 105 | Urticaria (HP:0001025) | 1.96251158 |
| 106 | Abnormality of placental membranes (HP:0011409) | 1.96082516 |
| 107 | Amniotic constriction ring (HP:0009775) | 1.96082516 |
| 108 | Petechiae (HP:0000967) | 1.96041571 |
| 109 | Premature graying of hair (HP:0002216) | 1.95593834 |
| 110 | Patellar aplasia (HP:0006443) | 1.93935240 |
| 111 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.93732038 |
| 112 | Thrombocytosis (HP:0001894) | 1.93387802 |
| 113 | Asplenia (HP:0001746) | 1.92779705 |
| 114 | Partial duplication of thumb phalanx (HP:0009944) | 1.91254058 |
| 115 | Renal Fanconi syndrome (HP:0001994) | 1.90507538 |
| 116 | Sparse eyelashes (HP:0000653) | 1.87352115 |
| 117 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.87102922 |
| 118 | Absent forearm bone (HP:0003953) | 1.86375173 |
| 119 | Aplasia involving forearm bones (HP:0009822) | 1.86375173 |
| 120 | Bone marrow hypocellularity (HP:0005528) | 1.86343699 |
| 121 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.86133265 |
| 122 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.86133265 |
| 123 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.86133265 |
| 124 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.84434874 |
| 125 | Dicarboxylic aciduria (HP:0003215) | 1.84434874 |
| 126 | Rib fusion (HP:0000902) | 1.84401138 |
| 127 | Opisthotonus (HP:0002179) | 1.84355837 |
| 128 | Abnormality of iron homeostasis (HP:0011031) | 1.84331117 |
| 129 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.83999699 |
| 130 | Ependymoma (HP:0002888) | 1.83862012 |
| 131 | Abnormal lung lobation (HP:0002101) | 1.82992396 |
| 132 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.82288177 |
| 133 | Mediastinal lymphadenopathy (HP:0100721) | 1.82164905 |
| 134 | Cerebral edema (HP:0002181) | 1.79286409 |
| 135 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.79004362 |
| 136 | Tracheoesophageal fistula (HP:0002575) | 1.78138945 |
| 137 | Glossoptosis (HP:0000162) | 1.78102836 |
| 138 | Axonal loss (HP:0003447) | 1.77523643 |
| 139 | Fused cervical vertebrae (HP:0002949) | 1.77234198 |
| 140 | Recurrent skin infections (HP:0001581) | 1.75994177 |
| 141 | Prolonged neonatal jaundice (HP:0006579) | 1.75866912 |
| 142 | Esophageal neoplasm (HP:0100751) | 1.75619158 |
| 143 | Neoplasm of head and neck (HP:0012288) | 1.75619158 |
| 144 | Abnormality of the 2nd finger (HP:0004100) | 1.75190749 |
| 145 | Rhabdomyosarcoma (HP:0002859) | 1.74974293 |
| 146 | Meningitis (HP:0001287) | 1.74661220 |
| 147 | Lactic acidosis (HP:0003128) | 1.74196001 |
| 148 | Fasciculations (HP:0002380) | 1.73311744 |
| 149 | Exercise intolerance (HP:0003546) | 1.72122643 |
| 150 | Prolonged bleeding time (HP:0003010) | 1.71877068 |
| 151 | Mucopolysacchariduria (HP:0008155) | 1.71318419 |
| 152 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.71318419 |
| 153 | Recurrent fungal infections (HP:0002841) | 1.71129262 |
| 154 | Epistaxis (HP:0000421) | 1.70690099 |
| 155 | Recurrent viral infections (HP:0004429) | 1.70175955 |
| 156 | Cellulitis (HP:0100658) | 1.70169644 |
| 157 | Seborrheic dermatitis (HP:0001051) | 1.69502860 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 4.02820146 |
| 2 | VRK2 | 3.44783627 |
| 3 | WEE1 | 3.33242946 |
| 4 | TESK2 | 3.29365177 |
| 5 | NME2 | 3.09881646 |
| 6 | EIF2AK1 | 3.06096754 |
| 7 | PIM2 | 2.23469703 |
| 8 | SMG1 | 2.18315515 |
| 9 | TTK | 2.17851631 |
| 10 | TESK1 | 2.17690364 |
| 11 | ERN1 | 2.17543577 |
| 12 | STK16 | 2.15267959 |
| 13 | EPHA2 | 2.09142617 |
| 14 | CDC7 | 1.99776010 |
| 15 | TRIB3 | 1.84453909 |
| 16 | CDK12 | 1.83218655 |
| 17 | EIF2AK3 | 1.82119334 |
| 18 | CDK7 | 1.79854278 |
| 19 | NEK2 | 1.72272525 |
| 20 | PBK | 1.68697506 |
| 21 | BCKDK | 1.64747496 |
| 22 | DYRK3 | 1.62428312 |
| 23 | MAP3K12 | 1.61340508 |
| 24 | SIK1 | 1.58197079 |
| 25 | PLK1 | 1.55612318 |
| 26 | PLK4 | 1.53820921 |
| 27 | MAP3K11 | 1.53181136 |
| 28 | STK10 | 1.51835892 |
| 29 | MAP4K1 | 1.46222478 |
| 30 | LIMK1 | 1.46112816 |
| 31 | VRK1 | 1.43327029 |
| 32 | BLK | 1.41409151 |
| 33 | GRK6 | 1.40488058 |
| 34 | SRPK1 | 1.36312257 |
| 35 | PRPF4B | 1.35312306 |
| 36 | CHEK2 | 1.35302666 |
| 37 | KDR | 1.34541259 |
| 38 | RPS6KB2 | 1.29778602 |
| 39 | FLT3 | 1.27858106 |
| 40 | PAK4 | 1.27783921 |
| 41 | NEK1 | 1.25851919 |
| 42 | MAP3K8 | 1.25375038 |
| 43 | MAPKAPK3 | 1.20268211 |
| 44 | AURKB | 1.18513076 |
| 45 | MST1R | 1.18416272 |
| 46 | BRAF | 1.17652494 |
| 47 | DAPK1 | 1.14971162 |
| 48 | AURKA | 1.12786365 |
| 49 | ILK | 1.10320625 |
| 50 | RIPK4 | 1.09957335 |
| 51 | MAP2K2 | 1.08348419 |
| 52 | SIK3 | 1.06784756 |
| 53 | RPS6KA4 | 1.04063823 |
| 54 | PASK | 1.03202707 |
| 55 | PIM1 | 1.01339276 |
| 56 | ADRBK2 | 1.00981454 |
| 57 | MATK | 1.00356268 |
| 58 | PAK1 | 0.99816355 |
| 59 | MAP2K3 | 0.96955054 |
| 60 | MST4 | 0.95856112 |
| 61 | ARAF | 0.95081322 |
| 62 | ABL2 | 0.94070633 |
| 63 | STK4 | 0.93731859 |
| 64 | DYRK2 | 0.93534622 |
| 65 | TAOK1 | 0.92601234 |
| 66 | BRSK2 | 0.92566470 |
| 67 | GRK1 | 0.89827248 |
| 68 | JAK3 | 0.88823512 |
| 69 | ATR | 0.87399750 |
| 70 | CSF1R | 0.87186971 |
| 71 | IRAK3 | 0.85417222 |
| 72 | LRRK2 | 0.81455215 |
| 73 | TLK1 | 0.81263993 |
| 74 | IKBKE | 0.80458468 |
| 75 | CDK4 | 0.80217739 |
| 76 | PRKG2 | 0.79708280 |
| 77 | ACVR1B | 0.78787108 |
| 78 | PRKCI | 0.77717314 |
| 79 | MET | 0.76241935 |
| 80 | CDK8 | 0.75644533 |
| 81 | IKBKB | 0.74241996 |
| 82 | ZAP70 | 0.73216343 |
| 83 | PDK2 | 0.70194377 |
| 84 | MYLK | 0.69796351 |
| 85 | CSNK2A1 | 0.68484507 |
| 86 | MAP3K10 | 0.68091576 |
| 87 | SCYL2 | 0.67549562 |
| 88 | NME1 | 0.65903065 |
| 89 | CDK19 | 0.65495975 |
| 90 | MAP3K3 | 0.65094369 |
| 91 | TNK2 | 0.64555487 |
| 92 | DAPK3 | 0.62043168 |
| 93 | MAP3K1 | 0.61964801 |
| 94 | PTK6 | 0.61807744 |
| 95 | CHEK1 | 0.61406750 |
| 96 | BMX | 0.60935202 |
| 97 | GRK5 | 0.56311226 |
| 98 | CSNK2A2 | 0.55866980 |
| 99 | MOS | 0.55041448 |
| 100 | IRAK2 | 0.55034378 |
| 101 | IRAK4 | 0.53661178 |
| 102 | BTK | 0.53359072 |
| 103 | TGFBR1 | 0.52177422 |
| 104 | PRKD2 | 0.51433125 |
| 105 | MAPKAPK2 | 0.51016260 |
| 106 | MUSK | 0.50595624 |
| 107 | EPHB1 | 0.49051950 |
| 108 | TBK1 | 0.47546464 |
| 109 | PDPK1 | 0.45844915 |
| 110 | TSSK6 | 0.45245488 |
| 111 | MARK3 | 0.44898085 |
| 112 | CDK2 | 0.44123875 |
| 113 | EIF2AK2 | 0.42675205 |
| 114 | MAP3K14 | 0.42597509 |
| 115 | LYN | 0.42557632 |
| 116 | CLK1 | 0.42288556 |
| 117 | MAPK11 | 0.41596900 |
| 118 | ATM | 0.40291517 |
| 119 | TEC | 0.40186092 |
| 120 | TAOK2 | 0.39592454 |
| 121 | KIT | 0.39217987 |
| 122 | TYK2 | 0.38266236 |
| 123 | HCK | 0.37194892 |
| 124 | AKT2 | 0.36249079 |
| 125 | RPS6KA5 | 0.35683973 |
| 126 | ZAK | 0.35213112 |
| 127 | PTK2 | 0.35136515 |
| 128 | PRKCD | 0.35011134 |
| 129 | ICK | 0.34095124 |
| 130 | MKNK1 | 0.32286233 |
| 131 | STK39 | 0.30981918 |
| 132 | CSK | 0.30927515 |
| 133 | PKN2 | 0.30114385 |
| 134 | BRSK1 | 0.29930650 |
| 135 | PLK3 | 0.27272106 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 3.94501079 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 3.81959921 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 3.73766528 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 3.40468108 |
| 5 | RNA polymerase_Homo sapiens_hsa03020 | 2.99885141 |
| 6 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.77174965 |
| 7 | Homologous recombination_Homo sapiens_hsa03440 | 2.51301537 |
| 8 | Base excision repair_Homo sapiens_hsa03410 | 2.47311715 |
| 9 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.37505597 |
| 10 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.20870209 |
| 11 | Spliceosome_Homo sapiens_hsa03040 | 2.18180087 |
| 12 | RNA transport_Homo sapiens_hsa03013 | 2.05664969 |
| 13 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.01502392 |
| 14 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.88837101 |
| 15 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.81726716 |
| 16 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.79448556 |
| 17 | Sulfur relay system_Homo sapiens_hsa04122 | 1.72141595 |
| 18 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.70269874 |
| 19 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.68023494 |
| 20 | Lysosome_Homo sapiens_hsa04142 | 1.65733393 |
| 21 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.64709105 |
| 22 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.56977326 |
| 23 | Parkinsons disease_Homo sapiens_hsa05012 | 1.48799112 |
| 24 | Cell cycle_Homo sapiens_hsa04110 | 1.44963378 |
| 25 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.43500962 |
| 26 | Protein export_Homo sapiens_hsa03060 | 1.42620613 |
| 27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.31482382 |
| 28 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.30545264 |
| 29 | Basal transcription factors_Homo sapiens_hsa03022 | 1.29755936 |
| 30 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.26682875 |
| 31 | Huntingtons disease_Homo sapiens_hsa05016 | 1.25348918 |
| 32 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.20465275 |
| 33 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.19245624 |
| 34 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.18847312 |
| 35 | Galactose metabolism_Homo sapiens_hsa00052 | 1.16006923 |
| 36 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.13569250 |
| 37 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.12953709 |
| 38 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.10430358 |
| 39 | Purine metabolism_Homo sapiens_hsa00230 | 1.04737960 |
| 40 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.03990649 |
| 41 | RNA degradation_Homo sapiens_hsa03018 | 1.03240482 |
| 42 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.02293431 |
| 43 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.01836890 |
| 44 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.99919539 |
| 45 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.99765182 |
| 46 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.99537272 |
| 47 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.99506731 |
| 48 | Allograft rejection_Homo sapiens_hsa05330 | 0.97081717 |
| 49 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.94194419 |
| 50 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.93236334 |
| 51 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.92251197 |
| 52 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.91488810 |
| 53 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.87810369 |
| 54 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.87789043 |
| 55 | Carbon metabolism_Homo sapiens_hsa01200 | 0.85020625 |
| 56 | Alzheimers disease_Homo sapiens_hsa05010 | 0.84690382 |
| 57 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.83816077 |
| 58 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.82711992 |
| 59 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.80495987 |
| 60 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.75412587 |
| 61 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.74460091 |
| 62 | Legionellosis_Homo sapiens_hsa05134 | 0.74109894 |
| 63 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.73716107 |
| 64 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.73106236 |
| 65 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.72687239 |
| 66 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.72529578 |
| 67 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.72465895 |
| 68 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.71055341 |
| 69 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.70895200 |
| 70 | Metabolic pathways_Homo sapiens_hsa01100 | 0.70024412 |
| 71 | Asthma_Homo sapiens_hsa05310 | 0.69509245 |
| 72 | Tuberculosis_Homo sapiens_hsa05152 | 0.67905519 |
| 73 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.67678411 |
| 74 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.67243310 |
| 75 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.66919912 |
| 76 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.65214659 |
| 77 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.64409400 |
| 78 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.63096031 |
| 79 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.62397542 |
| 80 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.62392126 |
| 81 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.62197469 |
| 82 | Thyroid cancer_Homo sapiens_hsa05216 | 0.61777774 |
| 83 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.61325663 |
| 84 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.60797017 |
| 85 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.60188569 |
| 86 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.59093196 |
| 87 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.58333291 |
| 88 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.55706084 |
| 89 | Hepatitis C_Homo sapiens_hsa05160 | 0.55450480 |
| 90 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.55013344 |
| 91 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.54050784 |
| 92 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.52225151 |
| 93 | Viral myocarditis_Homo sapiens_hsa05416 | 0.51883546 |
| 94 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.51770322 |
| 95 | Phagosome_Homo sapiens_hsa04145 | 0.51646516 |
| 96 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.51122859 |
| 97 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.50804209 |
| 98 | Influenza A_Homo sapiens_hsa05164 | 0.50634837 |
| 99 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.49960279 |
| 100 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.49178347 |
| 101 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.44635096 |
| 102 | Histidine metabolism_Homo sapiens_hsa00340 | 0.44578839 |
| 103 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.44435362 |
| 104 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.44325519 |
| 105 | Pertussis_Homo sapiens_hsa05133 | 0.43815167 |
| 106 | Peroxisome_Homo sapiens_hsa04146 | 0.43723811 |
| 107 | Other glycan degradation_Homo sapiens_hsa00511 | 0.42931969 |
| 108 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.42913715 |
| 109 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.42477811 |
| 110 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.42013773 |
| 111 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.41047282 |
| 112 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.40895398 |
| 113 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.37486474 |
| 114 | Shigellosis_Homo sapiens_hsa05131 | 0.35404078 |
| 115 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.33609842 |
| 116 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.32145399 |
| 117 | Leishmaniasis_Homo sapiens_hsa05140 | 0.31793053 |
| 118 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.31468255 |
| 119 | Apoptosis_Homo sapiens_hsa04210 | 0.30513817 |
| 120 | Bladder cancer_Homo sapiens_hsa05219 | 0.28547100 |
| 121 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.27965559 |
| 122 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.27780661 |
| 123 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.26910394 |
| 124 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.23610075 |
| 125 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.23150436 |
| 126 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.22919991 |
| 127 | Salmonella infection_Homo sapiens_hsa05132 | 0.22593229 |
| 128 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.22508449 |
| 129 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.22178373 |
| 130 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.22022112 |
| 131 | Measles_Homo sapiens_hsa05162 | 0.21188624 |
| 132 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.21023763 |
| 133 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.20063392 |
| 134 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.19140470 |

